Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic Anemia
Sharon A Savage1, Mathias Viard2, Colm O'hUigin3
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
Genetic variations in the major histocompatibility complex, specifically HLA-DPB1 and HLA-B, are linked to an increased risk of severe aplastic anemia (SAA). These findings shed light on the immune system's role in SAA development.
Area of Science:
- Immunogenetics
- Hematology
- Genomics
Background:
- Severe aplastic anemia (SAA) is a rare, life-threatening condition characterized by bone marrow failure and pancytopenia.
- The exact causes of acquired SAA are unknown but are suspected to involve immune dysregulation and environmental factors.
Purpose of the Study:
- To investigate the genetic underpinnings of severe aplastic anemia (SAA) through a genome-wide association study (GWAS).
- To identify specific genetic variants within the major histocompatibility complex (MHC) associated with SAA susceptibility.
Main Methods:
- Conducted a genome-wide association study (GWAS) with discovery and validation cohorts, comparing SAA cases to healthy controls.
- Utilized SNP analysis within the MHC region on chromosome 6p21, focusing on HLA class II (HLA-DPB1) and class I (HLA-B) genes.
- Performed phylogenetic analysis and imputed HLA-DPB1 alleles to assess the functional impact of identified genetic variations.
Main Results:
- Identified significant single nucleotide polymorphisms (SNPs) in HLA-DPB1, including rs1042151 (p.Met76Val), strongly associated with SAA risk (p = 1.94 × 10-13).
- The Met76Val substitution in HLA-DPB1 was linked to altered HLA-DP cell surface expression and increased SAA risk with specific alleles (DPB1∗03:01, DPB1∗10:01, DPB1∗01:01).
- A second SNP near HLA-B (rs28367832) also reached genome-wide significance, suggesting a potential role for HLA class I genes in SAA pathogenesis.
Conclusions:
- Genetic variations in HLA-DPB1 and potentially HLA-B are associated with an increased risk of developing severe aplastic anemia.
- The identified HLA-DPB1 variants, particularly those encoding the p.Met76Val substitution, may influence SAA risk through altered peptide binding specificity or expression levels.
- These findings highlight the role of immune response genes in the etiology of SAA and offer potential targets for future research.
More Related Videos
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
08:07Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
